Skip to main content
ERNA logo

ERNA · Ernexa Therapeutics Inc. · Holdings

Track ERNA — free
$2.24 +0.26 (+13.13%)
Market Cap
$3.23M
Shares
1.63M
Volume · Oct 20 47.46K Avg daily vol (3M) 56.93K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Institutional holdings are being reconciled with SEC filings. Holder totals and changes may be incomplete until reconciliation finishes.
Holders: 17
Total Value: $236,238
Total Shares: 2,872,344

Institutional Ownership Trend

22 quarters

Holder Concentration

Across 17 13F filers · Δ vs Mar 31, 2026
Top Holder
42.5%
Sep 2023 → Jun 2026 · range 19.7% – 84.7%
−13.4 pts
Top 5
99.9%
Sep 2023 → Jun 2026 · range 69.4% – 99.9%
+6.2 pts
Top 10
100.0%
Sep 2023 → Jun 2026 · range 89.8% – 100.0%
+1.4 pts
HHI
2,901
Sep 2023 → Jun 2026 · range 1,189 – 7,243
Highly concentrated−729

Who Holds ERNA

Last 8 quarters through Jun 30, 2026

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Jun 30, 2026: 15 filers, like-for-like change -58.6%; actively managed books -58.8%; index-like books +11.9%.

Holder type Share Filers Change
Registered adviser 75.9% 6 -64.3%
Bank 0.0% 0 -100.0%
Non-US 0.0% 2 new
Holding company 0.0% 1 -95.3%
Broker-dealer 0.0% 0 —
Exempt adviser 0.0% 0 —
Unknown 24.1% 6 -17.2%
How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Conviction and Crowding

9 13F filers, quarter ended Jun 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
0
0.000% of filers hold it in their top 10
Mar 31, 2026: 0
Holders above 5%
0
median weight 0.000%
Mar 31, 2026: 0
Crowding
1.84%
of shares outstanding, not ranked: fewer than 10 13F filers, too few to rank
Mar 31, 2026: 9.57%
Private-fund advisers
1.29%
of shares outstanding
Institutional ownership
3.05%
3.97% of the estimated free float
Top 10 holders
100.0%
of 13F shares, Herfindahl 0.290
Active holders
-83.5%
like-for-like share change of active filers
5% stakes on record
5
1 13D, 4 13G (1 institutional, 3 passive, 0 exempt)
How long holders have held it value-weighted 2.0 quarters
Under 1 year 99.9% 1 to 3 years 0.109% 3 years or more 0.000% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net buyers of $0 (0 buying, 0 selling).

Estimated Holder Cost Basis

Quarter ended Jun 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$16.06
estimated per share
Mar 31, 2026: $0.64
Quarter-end price
$6.65
implied by 13F values
Estimated gain or loss
-58.6%
price against the estimated cost
Estimated at a loss
100.0%
of costed 13F value

Estimated cost covers 16.9% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shareholder Targets

13F filers that own its peers but not ERNA, quarter ended Jun 30, 2026

ERNA has no holder-overlap peers, so these filers hold the largest Healthcare stocks: LLY, JNJ, ABBV, UNH, MRK, TMO, AMGN, AZN, GILD, ABT, ISRG, VRTX, CVS, DHR, SYK, BMY, PFE, MDT, MCK, ELV. 6,276 filers in all.

# Filer In peers
1 STATE STREET CORP Bank, Index-like $222,713,276,889 20 held
2 VANGUARD PORTFOLIO MANAGEMENT LLC Registered adviser, Diversified active $116,012,260,024 20 held
3 GEODE CAPITAL MANAGEMENT, LLC Registered adviser, Index-like $112,944,926,328 19 held
4 LILLY ENDOWMENT INC Unknown, Unknown $108,400,867,760 1 held
5 FMR LLC Holding company, Diversified active $102,008,860,554 20 held
6 JPMORGAN CHASE & CO Bank, Diversified active $92,751,126,760 20 held
7 MORGAN STANLEY Holding company, Index-like $91,022,115,433 20 held
8 Capital World Investors Adviser, Diversified active $89,827,396,720 14 held
9 NORGES BANK Non-US, Index-like $70,478,623,091 20 held
10 PRICE T ROWE ASSOCIATES INC /MD/ Registered adviser, Diversified active $69,817,479,779 20 held

Fund Ownership of ERNA by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 0.84% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 0.49% 7,988
Index ETFs 0.35% 5,684
Active ETFs 0.00% 0
Active funds 0.00% 1
Unclassified 0.00% 0
All registered funds 0.84% 13,673
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Quarterly Activity

vs Mar 31, 2026
New
3
Increased
9
Decreased
1
Sold Out
9
Unchanged
4

New and Sold Out count only filers that reported a 13F for both quarters: a first-time filer's book is not a buy, and a fund that has not filed, or withheld its positions under confidential treatment, has not sold.

Holder count: -6
Institutional value: -67.0%
Shares held: -72.3%

Top Buyers

vs Mar 31, 2026
Institution Added Now Holds Open

Top Sellers

vs Mar 31, 2026
Institution Sold Now Holds Open

Top New Positions

vs Mar 31, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Mar 31, 2026
Institution Previously Held Last Value (USD) Open
Showing 17 of 17
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 748592 CUSIP 114082407 Visit website Investor relations